Key takeaways:

The AMALFI trial evaluated a completely remote approach to atrial fibrillation screening.

Remote screening with a wearable ECG monitor “modestly” increased detection and treatment at 2.5 years in older adults.

A remote screening strategy for asymptomatic atrial fibrillation involving use of an ECG patch for continuous ambulatory monitoring conferred a modest increase in AF diagnoses after 2.5 years among older adults at risk for stroke.

The fully remote, randomized AMALFI trial evaluated long-term efficacy of AF screening via use of a 14-day patch-based continuous ambulatory ECG monitor (Zio XT, iRhythm) sent to participants by mail.

The AMALFI trial evaluated a completely remote approach to atrial fibrillation screening. Image: Adobe Stock

The patch detected AF in

See Full Page